Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $15.00 at Piper Sandler

Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) had its target price boosted by analysts at Piper Sandler from $14.00 to $15.00 in a note issued to investors on Monday, The Fly reports. Piper Sandler’s price objective suggests a potential upside of 134.38% from the stock’s current price. ADPT has been the subject of a number of […]

Related Keywords

Chad ,Piper Sandler ,Stacyl Taylor ,Harlan Robins ,R Mark Adams ,Healthcare Of Ontario Pension Plan Trust Fund ,Morgan Stanley ,Adaptive Biotechnologies Corp ,Credit Suisse Group ,Metlife Investment Management ,Securities Exchange Commission ,Meeder Asset Management Inc ,Financial Services Group Inc ,Adaptive Biotechnologies ,Get Rating ,Suisse Group ,Exchange Commission ,Mark Adams ,Services Group ,Asset Management ,Life Investment Management ,Ontario Pension Plan Trust Fund ,Chad Robins ,Chris Carlson ,Adaptive Biotechnologies Daily ,Nasdaq Adpt ,Adpt ,Medical ,Boost Price Target ,